Additionally, high CD133 tumor expression was associated with a higher relative risk of patients’ death (HR = 3.237, p = 0.014) compared with high CD166 tumor expression (HR = 2.866, p = 0.020), as assessed by a multivariate Cox analysis (Table 6). This evidence concerns the gene ALCAM and neoplasm.